Wakefield Asset Management L »

Aurinia Pharmaceuticals shares owned by Wakefield Asset Management L

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Wakefield Asset Management L from 13F filings

Historical chart of Wakefield Asset Management L investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Wakefield Asset Management L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Wakefield Asset Management L

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 78k 15.95

More positions owned by Wakefield Asset Management L

Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Technipfmc (FTI)
Newmont Mining Corporation (NEM)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Expedia Group Com New (EXPE)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Lam Research Corp Com New (LRCX)
Aercap Holdings Nv SHS (AER)
Amphenol Corp Cl A (APH)

View all positions for Wakefield Asset Management L

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Renaissance Technologies
Marshall Wace
Geode Capital Management
Jane Street
Vanguard Group
Two Sigma Investments
Nomura Holdings
Jacobs Levy Equity Management
Henderson Group
Goldman Sachs Group

View all funds holding Aurinia Pharmaceuticals